MORABITO, FORTUNATO
 Distribuzione geografica
Continente #
EU - Europa 85
Totale 85
Nazione #
IT - Italia 85
Totale 85
Città #
Rome 58
Gioiosa Ionica 23
Lamezia Terme 4
Totale 85
Nome #
Myelodysplastic syndromes with ring sideroblasts, file e11ac152-dc2f-4ab3-9f8c-e73c528e7017 7
Safety and efficacy of caplacizumab in a case of thrombotic thrombocytopenic purpura in the postpartum period, file 84444741-7ecf-4514-8f97-4883d54eef1d 6
Safe and Effective Administration of Caplacizumab in COVID-19-Associated Thrombotic Thrombocytopenic Purpura, file d25f0151-63fb-4b7b-8fc1-1c2067496d31 5
Acalabrutinib in chronic lymphocytic leukemia, file 0322a7aa-e716-413d-baf0-5cf55bd8f9f2 4
Lymphocyte Doubling Time As A Key Prognostic Factor To Predict Time To First Treatment In Early-Stage Chronic Lymphocytic Leukemia, file 2dbc7cb5-e93e-4c87-ac6d-d70193703aae 4
Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3-year follow-up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials, file 5e146688-8155-4947-b4c6-a2cc0f6836c3 4
Adjusted comparison between elotuzumab and carfilzomib in combination with lenalidomide and dexamethasone as salvage therapy for multiple myeloma patients, file 730e8026-212b-4a79-b648-e4d094ddcbcb 4
Isatuximab in multiple myeloma, file 776f4e0e-ad9e-49cd-879b-3664c83e2080 4
Carfilzomib combined with lenalidomide and dexamethasone (KRd) as salvage therapy for multiple myeloma patients: italian, multicenter, retrospective clinical experience with 600 cases outside of controlled clinical trials, file 83e09d9e-4612-4446-88a1-01a710493976 4
Elotuzumab in multiple myeloma, file c9cddd10-aa59-47cd-b154-98c2c147afe2 4
Zanubrutinib for the treatment of chronic lymphocytic leukemia, file ccf8894b-d154-45cf-8afb-a7689383758e 4
Venetoclax in acute myeloid leukemia, file d91f253d-75a9-4140-9f32-5ca05acb5ed2 4
Validation of the Alternative International Prognostic Score-E (AIPS-E): Analysis of Binet stage A chronic lymphocytic leukemia patients enrolled into the O-CLL1-GISL protocol, file f5a03718-9a3d-420f-bd65-2034a9adc049 4
Belantamab mafodotin in multiple myeloma, file 14a801e1-d596-414c-9ad4-8db522cd7b33 2
Iron chelation therapy, file 1dfc79b8-0148-4ab4-9482-c76cf64a3588 2
Tagraxofusp in myeloid malignancies, file 4ee8472b-a624-44e5-91b9-dee2d93c3237 2
Mechanisms of Immune Evasion in Multiple Myeloma: Open Questions and Therapeutic Opportunities, file 636ea4d0-1d16-4a0f-aae4-a622c6cec45e 2
Glasdegib for the treatment of acute myeloid leukemia, file 804aff4e-5107-4695-9503-fac90e431993 2
Spotlight on Melphalan Flufenamide: An Up-and-Coming Therapy for the Treatment of Myeloma, file 81c052a3-3263-4024-bd4f-df3edaa1e73a 2
Survival Risk Scores for Real-Life Relapsed/Refractory Multiple Myeloma Patients Receiving Elotuzumab or Carfilzomib In Combination With Lenalidomide and Dexamethasone as Salvage Therapy: Analysis of 919 Cases Outside Clinical Trials, file 85b4b71b-b9a2-4815-a6d4-f3b29133abc6 2
Clinical impact of TP53 disruption in chronic lymphocytic leukemia patients treated with ibrutinib: a campus CLL study, file 88ca3e9f-3451-437d-9f45-1f6abf41ee46 2
Assessment of the 4-factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study, file abfaf3c2-c279-4cf4-84f0-01ebd97acdbd 2
Comparison of ibrutinib and idelalisib plus rituximab in real-life relapsed/resistant chronic lymphocytic leukemia cases, file b1811dac-0762-4cdd-93d2-5a90732f7562 2
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: a multicenter, retrospective real-world experience with 200 cases outside of controlled clinical trials, file b480e67a-d732-4a6e-b442-eb4c33a2857f 2
Ivosidenib in acute myeloid leukemia, file e577ed41-4975-4140-a18b-21dd973314da 2
The time to first treatment is an independent predictor of overall survival in chronic lymphocytic leukemia, file e806c803-be51-401a-9258-acba8414b73b 2
Teclistamab-cqyv in multiple myeloma, file 7749fa58-0fa5-43ff-b98e-fe0f98567225 1
Totale 85
Categoria #
all - tutte 87
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20234 0 0 0 0 0 0 0 0 4 0 0 0
2023/202481 0 0 0 0 0 58 23 0 0 0 0 0
Totale 85